Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The US EPA has proposed the approval of Bayer legacy company Monsanto's biopesticide plant growth regulator, LCO (lipochitooligosaccharide) MOR116.
The US EPA has proposed the approval of Canadian company Bee Vectoring Technologies' (BVT – Mississauga, Ontario) bee vectored biofungicide, Vectorite with CR-7 (Clonostachys rosea strain CR-7).
The US EPA has proposed the approval of Swiss biopesticide company Andermatt Biocontrol's viral insecticide, Loopex (Autographa californica multiple nucleopolyhedrovirus strain FV#11), for the control of cabbage loopers (Trichoplusia ni).
UK biological crop protection company Eden Research's commercial partner, Sumitomo Corporation subsidiary Sumi Agro France, has received a 120-day "emergency use" authorisation in France for Eden's biofungicide, Mevalone.
The Brazilian national health surveillance agency, the Anvisa, has recommended the approval of two biological pesticides as new active ingredients.
The Canadian Pest Management Regulatory Agency has proposed the continued registration of Finnish company Verdera's biofungicide, Mycostop (Streptomyces griseoviridis strain K61), following a re-evaluation of the active ingredient.
EU member states have voted in favour of proposed approvals of two biofungicides.
FMC has submitted applications for two new biofungicides and associated formulated products to the US EPA Office of Pesticide Programs Biopesticides and Pollution Prevention Division (BPPD).
The Australian Pesticides and Veterinary Medicines Authority (APVMA) has approved BASF's biofungicide, Serifel (Bacillus amyloliquefaciens strain MBI 600).
New EU legislation that brings plant biostimulants within the scope of revised laws on fertilisers comes into force on July 15th.
The US-based, UK-listed bioproducts company, Plant Health Care (PHC – Raleigh, North Carolina), has agreed a distribution deal with US agrochemical distributor Wilbur-Ellis (Walnut Creek, California) for its disease resistance activator, Harpin αβ technology.
The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), has been granted “key claims” by the US Patent and Trademark Office for aspects of its bioinsecticide, Grandevo (Chromobacterium subtsugae strain PRAA4-1T).
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.